These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11427616)
1. New aspects in the management of ANCA-positive vasculitis. Levy J Nephrol Dial Transplant; 2001 Jul; 16(7):1314-7. PubMed ID: 11427616 [No Abstract] [Full Text] [Related]
2. Part 3: Newer therapies for ANCA-associated vasculitis. Jayne D Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S77-9. PubMed ID: 17428377 [No Abstract] [Full Text] [Related]
3. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides. Guillevin L; Pagnoux C Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585 [TBL] [Abstract][Full Text] [Related]
5. Part 1: The need for novel treatment regimens for ANCA-associated vasculitis. Merkel PA Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S72-3. PubMed ID: 17428375 [No Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Jayne DR; Chapel H; Adu D; Misbah S; O'Donoghue D; Scott D; Lockwood CM QJM; 2000 Jul; 93(7):433-9. PubMed ID: 10874052 [TBL] [Abstract][Full Text] [Related]
7. Systemic vasculitis treatment and monitoring update, 2008. Yazici Y Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637 [TBL] [Abstract][Full Text] [Related]
8. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis. Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G; Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121 [No Abstract] [Full Text] [Related]
10. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome]. Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659 [TBL] [Abstract][Full Text] [Related]
11. ANCA +ve vasculitis after autologous PBSC transplantation. Kingdon EJ; Johnston RE; Pawson R; Prentice HG; Potter MN; Burns A; Powis SH Nephrol Dial Transplant; 2002 Feb; 17(2):285-7. PubMed ID: 11812882 [No Abstract] [Full Text] [Related]
12. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. Jayne DR; Esnault VL; Lockwood CM J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059 [TBL] [Abstract][Full Text] [Related]
13. ANCA-positive vasculitis. Kamesh L; Harper L; Savage CO J Am Soc Nephrol; 2002 Jul; 13(7):1953-60. PubMed ID: 12089393 [No Abstract] [Full Text] [Related]
14. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside. Yoshida M Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592 [No Abstract] [Full Text] [Related]
16. Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil. Sun Q; Cheng D; Wen J; Chen J; Gong D; Liu Z; Li L Transplant Proc; 2008 Dec; 40(10):3764-6. PubMed ID: 19100484 [TBL] [Abstract][Full Text] [Related]
17. Pooled intravenous immunoglobulin in the management of systemic vasculitis. Jayne DR; Lockwood CM Adv Exp Med Biol; 1993; 336():469-72. PubMed ID: 8296659 [TBL] [Abstract][Full Text] [Related]
18. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis. Casian A; Jayne D Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082 [TBL] [Abstract][Full Text] [Related]